Clinical Trials Logo

Advanced Colorectal Cancer clinical trials

View clinical trials related to Advanced Colorectal Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03524274 Withdrawn - Clinical trials for Advanced Colorectal Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Start date: April 5, 2018
Phase: Phase 2
Study type: Interventional

This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced colorectal cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for colorectal cancer.

NCT ID: NCT02038699 Withdrawn - Clinical trials for Advanced Non-small Cell Lung Cancer

A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

Start date: January 2014
Phase: Phase 1/Phase 2
Study type: Interventional

ONC201 is a new potential drug that kills cancer cells but not normal cells in laboratory studies. This clinical trial will be the first evaluation of ONC201 in humans and will enroll patients with advanced cancer. This trial includes a phase I portion that will evaluate the safety of ONC201 and the recommended dose for the phase II portion. The phase II portion will evaluate the initial efficacy profile of ONC201 in select types of cancer.